GENE ONLINE|News &
Opinion
Blog

Technology
CYTENA Bioprocess Solutions Closes $5M Funding to Develop Automatic High-throughput Screening Platform for Pharmaceuticals
2021-10-05Partner
Taiwan’s AMS BioteQ Develops a New Antimicrobial Dressing Which Accelerates Diabetes Wound Healing
2021-09-22Partner
Foundation Medicine Enters Partnership With Epic to Integrate Genomic Insights into EMR Systems
2021-08-30
Eli Lilly, Lycia Partnership Signifies the Growing Targeted Protein Degradation Market
2021-08-27
Scientists Unveil Novel Protein That Delivers Molecular Medicines to Human Cells
2021-08-25
Engineered Human Brain Organoids Develops Primitive Eye Like Structures
2021-08-19
Scientists Develop Drug Inducible Switch to Regulate Gene Therapy
2021-08-18
Can the Gut Microbiome Prevent Age-Related Decline of Brain Function?
2021-08-15
This CRISPR-Based Test Can Detect COVID-19 Variants From Your Spit
2021-08-13
Reversing Obesity: Cytokine Treatment Makes Obese Mice ‘Sweat Fat’, UPenn Study Finds
2021-08-07
VIRTUALMAN Breaking Barriers in Drug Development with AI Solutions
2021-08-05Partner
Realizing The Promise of Cell And Gene Therapies: Current Challenges And Future Opportunities
2021-08-02
Germline Editing in Marsupials Marks Another Milestone for CRISPR
2021-08-01
The Evolution of Cytokine Therapies for a Broad Spectrum of Disorders
2021-07-30
Reprogrammed CRISPR Tool Could Target Emerging SARS-CoV-2 Variants
2021-07-28
1 2 3 16
LATEST
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Shaping the Future of the Beauty Industry: Can Skin Microbiome Products Succeed Cosmetics?
2021-10-25
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Daiichi Sankyo to Launch mRNA Covid-19 Vaccine in 2022, Shionogi Presents Clinical Results of Covid-19 Oral Drug
2021-10-22
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!